.jpg)
.jpg)
01 Apr, 2020
Halozyme Therapeutics Stock Up After Partnership with Roche
Halozyme Therapeutics, Inc. (NASDAQ: HALO) stock up more than 18% on Thursday after the biotechnology company announced that it has licensed its ENHANZE® drug-delivery technology to Roche for exclusive development of an undisclosed therapeutic t..
.jpg)
Insmed Incorporated Shares Jumped More than 100% After Positive Clinical Trial Data
Insmed Incorporated (NASDAQ: INSM) stock jumped about 113% on Tuesday, after the biopharmaceutical company announced top-line data from its Phase 3 CONVERT study.The company announced that the global CONVERT study met its primary endpoint of culture..
NxStage Medical, Inc. Shares Spiked After Acquisition Agreement
NxStage Medical, Inc. (NASDAQ: NXTM) shares jumped 27% Monday, after the medical technology company announced that its Board of Directors has unanimously approved a definitive agreement under which Fresenius Medical Care will acquire all of th..
Molina Healthcare Reported Financial Results for the Second Quarter
This week, Molina Healthcare, Inc. (NYSE: MOH) announced its Q2 financial results, with a net loss but revenue beating expectations.For the second quarter of 2017, the company reported a net loss of $4.10 per share, compared with analysts’ est..
Endo to Remove Opioid Painkiller in U.S. After FDA Request
Endo International Plc. (NASDAQ: ENDP) announced on Thursday that it will voluntarily remove its powerful opioid painkiller, Opana ER, a month after the U.S. Food and Drug Administration's withdrawal request amid the growing opioid abuse crisis ..
@Newsletter
Sign Up for Weekly UpdatesOpt-into our eNewsletter NOW! For the Latest Trending Financial News Topics in Cannabis, Tech, Biotechs, Precious Metals, Energy, Renewable Energy and much more!
No articles found.
.jpg){kind=small}
All rights reserved.
No portion of Financialinsiders.com may be duplicated, redistributed or manipulated in any form without our consent, violators will be prosecuted to the full extent of the law. By accessing any information beyond this page, you agree to abide by the Privacy Policy and Terms of Use (Disclaimer).